Journal Mobile Options
Table of Contents
Vol. 214, No. 1, 2007
Issue release date: December 2006
Section title: Clinical and Laboratory Investigations
Dermatology 2007;214:52–57
(DOI:10.1159/000096913)

Recurrent Erysipelas: 47 Cases

Leclerc S.a, b · Teixeira A.a · Mahé E.b · Descamps V.b · Crickx B.b · Chosidow O.a
aDepartment of Internal Medicine, Hôpital de la Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie-Paris 6, bDepartment of Dermatology, Hôpital Bichat-Claude-Bernard, Université Paris VII, Paris, France

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Clinical and Laboratory Investigations

Received: 6/9/2006
Accepted: 7/28/2006
Published online: 12/22/2006
Issue release date: December 2006

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 2

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM

Abstract

Background:Recurrence is a common complication of erysipelas (cellulitis). Objectives:Todescribe the characteristics of patients with recurrent erysipelas and thereby, identify potential risk factors and evaluate prophylaxis efficacy. Methods:Data were retrospectively recorded from the files of 47 patients admitted to hospital between 1995 and 2003 for erysipelas recurrence. Studied variables included: general condition, regional and local factors, e.g. broken cutaneous barrier. Patient characteristics were used to construct tree-based models according to the classification and regression tree methodology. Results: Our patients suffered a mean of 4.1 recurrences. Cutaneous barrier disruption was observed in 81%, mainly intertrigo (60%). Antibiotic prophylaxis was taken by 68% of the patients for 30.6 months. After 1 and 2 years, 84 and 72% of the patients, respectively, were recurrence-free. Conclusion: Our results showed that erysipelas recurrence has the same risk factors as single episodes and underlines the potential benefit of oral or parenteral antibiotic prophylaxis to prevent recurrences.

© 2007 S. Karger AG, Basel


  

Author Contacts

Olivier Chosidow
Department of Dermatology and Allergology, Hôpital Tenon
4 rue de la Chine, FR–75020 Paris (France)
Tel. +33 1 56 01 76 72, Fax +33 1 56 01 64 58
E-Mail olivier.chosidow@tnn.aphp.fr

  

Article Information

Presented in part at the ‘Journées Dermatologiques de Paris’, 12 December 2003.

Received: June 9, 2006
Accepted: July 28, 2006
Number of Print Pages : 6
Number of Figures : 3, Number of Tables : 2, Number of References : 25

  

Publication Details

Dermatology

Vol. 214, No. 1, Year 2007 (Cover Date: December 2006)

Journal Editor: Saurat, J.-H. (Geneva)
ISSN: 1018–8665 (print), 1421–9832 (Online)

For additional information: http://www.karger.com/DRM


Article / Publication Details

First-Page Preview
Abstract of Clinical and Laboratory Investigations

Received: 6/9/2006
Accepted: 7/28/2006
Published online: 12/22/2006
Issue release date: December 2006

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 2

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.